Barr IG, Hurt AC, Iannello P, Tomasov C, Deed N. Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral Res. 2006 Aug 28
The prevention and control of disease caused by seasonal and potential pandemic influenza viruses is currently managed by the use influenza vaccines and antivirals. The adamantanes (amantadine and rimantadine) were the first antivirals licensed for use against influenza A viruses and have been used extensively in some countries. Since the early 2000s increased resistance to these drugs has been reported especially in the A(H3) viruses. In this study we analysed recent human influenza A strains isolated in Australia and regionally for evidence of resistance to adamantanes and found evidence of significant resistant emerging during 2005.
See Also:
Latest articles in those days:
- Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker 13 hours ago
- [preprint] Emergence and interstate spread of highly pathogenic avian influenza A(H5N1) in dairy cattle 2 days ago
- Modelling the transmission dynamics of H9N2 avian influenza viruses in a live bird market 2 days ago
- CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age 4 days ago
- Surveillance for highly pathogenic avian influenza A (H5N1) in a raptor rehabilitation center-2022 4 days ago
[Go Top] [Close Window]